Vasopressin increases the liver's production of glucose from non-sugar sources.
See the scientific wording
Vasopressin stimulates hepatic gluconeogenesis, resulting in increased endogenous glucose production.
Correlational — new studies may shift this
Observational3 good-quality studies link this claim to the outcome, but causation is not established.
What the research says
3 studies reviewedSupporting (3)
Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men
Cohort StudyHuman2015
This study found that higher levels of a hormone related to vasopressin are linked to a higher chance of developing diabetes, even when accounting for other risk factors. This suggests vasopressin may be making the liver produce more sugar.
Case-Control StudyIn vitro
This study shows that vasopressin tells the liver to break down stored sugar and make more new sugar, even without using the usual signals. This means vasopressin helps the liver produce more glucose, just like the claim says.
The control by vasopressin of carbohydrate and lipid metabolism in the perfused rat liver.
Case-Control StudyAnimal
This study showed that when vasopressin is added to a rat's liver in a lab dish, the liver releases more glucose — meaning it's making sugar from non-sugar stuff, like proteins or fats. So yes, vasopressin helps the liver make more glucose.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Vasopressin binds to liver cells and causes a surge in calcium inside them, which turns on enzymes that break down stored sugar and block enzymes that use sugar for energy. This forces the liver to release more glucose into the blood. Cortisol from the adrenal glands keeps this process running strongly.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting studies
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Vasopressin increases the liver's production of glucose from non-sugar sources.
Mechanism
3 studiesVasopressin tells liver cells to release more sugar by flipping a calcium switch that turns on sugar-breaking enzymes and turns off sugar-storing ones. The adrenal gland’s cortisol keeps this process running at full strength.
Vasopressin binds to liver cells and causes a surge in calcium inside them, which turns on enzymes that break down stored sugar and block enzymes that use sugar for energy. This forces the liver to release more glucose into the blood. Cortisol from the adrenal glands keeps this process running strongly.
Vasopressin binds to V1 receptors on hepatocytes.
Receptor activation triggers release of calcium from intracellular stores.
Elevated calcium activates calcium-dependent kinases that phosphorylate phosphorylase, glycogen synthase, and pyruvate kinase.
Phosphorylation activates phosphorylase to break down glycogen and inhibits glycogen synthase and pyruvate kinase to reduce glucose storage and utilization.
Hepatic glucose output increases due to net glycogenolysis and reduced glycolytic flux.
Adrenal-derived cortisol maintains full efficacy of vasopressin-induced glucose release by sustaining enzyme activity or expression.
Less supported by current evidence, but not ruled out
Vasopressin stimulates the pancreas to release more glucagon, which then acts on the liver to increase glucose production.
Vasopressin activates V1b receptors on pancreatic alpha cells.
Alpha cells increase secretion of glucagon.
Glucagon binds to hepatic receptors and activates cAMP-dependent pathways to stimulate glycogenolysis and gluconeogenesis.
Vasopressin triggers inflammation and stress hormone release, which together make the liver produce more glucose.
Vasopressin increases systemic inflammation markers such as CRP and endothelial dysfunction factors.
Vasopressin activates the hypothalamic-pituitary-adrenal axis, increasing cortisol production.
Cortisol enhances expression of gluconeogenic enzymes in the liver.
Evidence from Studies
Last searched 3mo ago
Supporting (3)
Community contributions welcome
Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men
This study found that higher levels of a hormone related to vasopressin are linked to a higher chance of developing diabetes, even when accounting for other risk factors. This suggests vasopressin may be making the liver produce more sugar.
This study shows that vasopressin tells the liver to break down stored sugar and make more new sugar, even without using the usual signals. This means vasopressin helps the liver produce more glucose, just like the claim says.
The control by vasopressin of carbohydrate and lipid metabolism in the perfused rat liver.
This study showed that when vasopressin is added to a rat's liver in a lab dish, the liver releases more glucose — meaning it's making sugar from non-sugar stuff, like proteins or fats. So yes, vasopressin helps the liver make more glucose.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Vasopressin's Effect on Hepatic Gluconeogenesis and Glucose Production in Humans
Population: Adults with normal or impaired glucose metabolism; Intervention: Intravenous vasopressin administration; Comparator: Saline placebo; Outcome: Hepatic glucose production measured by tracer methodology; Duration: Single-dose or short-term infusion studies.
Double-Blind, Placebo-Controlled Trial of Vasopressin Infusion on Hepatic Glucose Output in Healthy Adults
Population: Healthy adult volunteers; Intervention: IV vasopressin at physiological doses; Comparator: Saline infusion; Outcome: Hepatic glucose production via stable isotope tracer technique; Duration: Single-session infusion over 2–4 hours.
Prospective Cohort Study of Endogenous Glucose Production in Patients Receiving Vasopressin for Shock
Population: Critically ill patients receiving vasopressin for septic shock; Comparator: Patients receiving norepinephrine; Outcome: Serial measurements of hepatic glucose production via tracer methods; Duration: 72-hour monitoring period.
In Vitro Study of Vasopressin on Gluconeogenic Enzyme Activity in Human Hepatocyte Cultures
Population: Primary human hepatocytes or HepG2 cell line; Intervention: Exposure to vasopressin at varying concentrations; Comparator: Vehicle control; Outcome: Expression and activity of PEPCK and G6Pase enzymes; Duration: 6–24 hour exposure.
Animal Model Study of Vasopressin-Induced Hepatic Gluconeogenesis in Rats with Hepatic Portal Vein Cannulation
Population: Adult Sprague-Dawley rats; Intervention: Intravenous vasopressin infusion; Comparator: Saline-infused controls; Outcome: Hepatic glucose output measured via portal vein catheter and tracer dilution; Duration: 90-minute infusion period.